Journal of Lipid Research, Vol 29, 1481-1489, Copyright © 1988 by Lipid Research, Inc.

ARTICLES

Low density lipoprotein receptor degradation is influenced by a mediator protein(s) with a rapid turnover rate, but is unaffected by receptor up- or down-regulation

LA Casciola, DR van der Westhuyzen, W Gevers and GA Coetzee
Department of Medical Biochemistry, University of Cape Town Medical School, South Africa.

Treatment of cultured human skin fibroblasts with cycloheximide retarded the down-regulation of low density lipoprotein (LDL) receptor activity caused by 25-hydroxycholesterol. The rate of LDL receptor degradation, measured directly by means of [35S]methionine pulse-chase experiments, was also markedly inhibited by cycloheximide (or puromycin), suggesting that continuous synthesis of a short-lived mediator protein(s) was necessary for normal LDL receptor turnover. In the absence of cycloheximide, both the up- and down-regulation of LDL receptor activity took place with a half-time of approximately 12 hr. Pulse-chase measurements with [35S]methionine yielded a receptor half- life (t1/2) of 11.7 +/- 2.2 hr (n = 10) in up-regulated cells; the t1/2 in the partially down-regulated state was similar. The presence of LDL or 25-hydroxycholesterol did not alter this degradation rate. Regulation of LDL receptor activity under these various culture conditions therefore probably occurred solely as a result of changes in the rate of receptor synthesis. The cycloheximide-sensitive factor(s) that influences receptor turnover apparently did not play a regulatory role in the up- or down-regulation of the LDL receptor.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				K. N. Maxwell and J. L. Breslow Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype PNAS, May 4, 2004; 101(18): 7100 - 7105. [Abstract] [Full Text] [PDF]

				R. G. Wells, H. Yankelev, H. Y. Lin, and H. F. Lodish Biosynthesis of the Type I and Type II TGF-beta Receptors. IMPLICATIONS FOR COMPLEX FORMATION J. Biol. Chem., April 25, 1997; 272(17): 11444 - 11451. [Abstract] [Full Text] [PDF]

				J.F. G. van Roggen, D.R. van der Westhuyzen, G.A. Coetzee, A.D. Marais, K. Steyn, E. Langenhoven, and M.J. Kotze FH Afrikaner-3 LDL Receptor Mutation Results in Defective LDL Receptors and Causes a Mild Form of Familial Hypercholesterolemia Arterioscler. Thromb. Vasc. Biol., June 1, 1995; 15(6): 765 - 772. [Abstract] [Full Text]